tm logo
RG
Live/Registered
REGISTERED

on 11 Jun 2024

Last Applicant/ Owned by

Ste 201, Bldg 24, Blk C,218 Sangtian St.

Suzhou, Jiangsu

CN

215000

Serial Number

90981041 filed on 24th Aug 2021

Registration Number

7414310 registered on 11th Jun 2024

in the Principal Register

Correspondent Address

Suite 4500

Indianapolis, IN 46204

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

RG

Medical, biological, pharmaceutical, and veterinary preparations containing polypeptide encoding nucleic acids for the prevention and treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders;medical, biological, pharmaceutical, and veterinary prepar Read More

Classification Information


Class [005]
Pharmaceutical Products


Medical, biological, pharmaceutical, and veterinary preparations containing polypeptide encoding nucleic acids for the prevention and treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders;medical, biological, pharmaceutical, and veterinary preparations for medical and pharmaceutical use, namely, preparations for preventing and treating rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders, and reproductive disorders; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites; cell-based immunotherapeutic treatment by way of genetically modified cells, medicated serums for the treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; attenuated viruses and particles similar to viruses, namely, encapsulated nucleic acids for the treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; diagnostic reagents and diagnostic preparations for medical purposes; chemical reagents used for medical or veterinary purposes; biochemical reagents used for medical or veterinary purposes for the treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases; adjuvants for medical purposes; macromolecules, namely, nucleic acid sequences and proteins, used for medical and veterinary purposes; a full line of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, biosimilars and therapeutics for the treatment of infectious diseases and cancer; vaccines; a full line of pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics for the treatment of infectious diseases and cancer


First Use Date in General

09th Feb 2024

First Use Date in Commerce

09th Feb 2024

Mark Details


Serial Number

No 90981041

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.29 -

Helixes

27.03.05 -

Representations of objects forming letters or numerals, including punctuation

Legal History


Show more

Status DateAction Taken
11th Jun 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
11th Jun 2024REGISTERED-PRINCIPAL REGISTER
09th May 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09th May 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
09th May 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09th May 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08th May 2024STATEMENT OF USE PROCESSING COMPLETE
08th May 2024DIVISIONAL PROCESSING COMPLETE
08th May 2024SOU EXTENSION 3 GRANTED
23rd Apr 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL